Axios Research
  • About Us
  • Products
  • Services
  • Support
  • Careers
  • Quote Cart

Products

Picture of Almotriptan Hydrazine Precursor HCl
Almotriptan

Almotriptan Hydrazine Precursor HCl

  • Catalogue #: AR-A01695
  • CAS #: 334981-11-2
  • Alternate CAS #: —
  • Molecular Formula: C₁₁H₁₇N₃O₂S. HCl
  • Molecular weight: 255.34 36.46
H.S. code:29359090
Inventory Status:         Enquire
1-((4-hydrazinylbenzyl)sulfonyl)pyrrolidine hydrochloride;1-((4-Hydrazinylbenzyl)sulfonyl)pyrrolidine hydrochloride;4-(1-Pyrrolidinylsulforylmenthyl)phenylhydrazine hydrochloride;1-[[(4-Hydrazinylphenyl)methyl]sulfonyl]pyrrolidine hydrochloride;1-((4-Hydrazinylbenzyl)sulfonyl)-pyrrolidine hydrochloride;4-(Pyrrolidinosulfonylmethyl) phenylhydrazine hydrochloride;[4-(1-pyrrolidinylsulfonylmethyl)phenyl]hydrazine hydrochloride;[4-(pyrrolidin-1-ylsulfonylmethyl)phenyl]diazane hydrochloride;4-(1-Pyrrolidinylsulforylmethyl)phenylhydrazine hydrochloride

Almotriptan Hydrazine Precursor HCl is a fully characterized chemical compound used as a reference standard of API Almotriptan Hydrazine Precursor HCl. The standard offered is compliant with regulatory guidelines. Almotriptan Hydrazine Precursor HCl is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 334981-11-2

Related Products

Almotriptan Malate

Almotriptan Malate

M.F. C₁₇H₂₅N₃O₂S. C₄H₆O₅

M.W. 335.47 134.09

CAT# AR-A01687

CAS# 181183-52-8

Axios Research

Quick Links

  • About Us
  • Services
  • Support
  • Career
  • Quote Cart

Contact

  • location20 De Boers Drive,
    Suite No. 540 Toronto,
    Ontario, Canada, M3J 0H1
  • phone416-623-0933
  • emailInfo@Axios-Research.com

Newsletter

© Copyright Axios Research 2024. All Rights Reserved.

Website Design by:Axios Research